Rivaroxaban Plus Aspirin Shows Favorable Benefit-Risk Profile in PAD Patients after revascularization, suggests study Dr Riya Dave20 April 2024 8:30 AM ISTThe VOYAGER PAD trial evaluated the efficacy and safety of rivaroxaban plus aspirin compared to aspirin alone in patients with symptomatic peripheral...
FDA approves oral daprodustat for treating anaemia in CKD patients on dialysis Dr. Kamal Kant Kohli3 Feb 2023 11:15 AM ISTThe US Food and Drug Administration (FDA) has approved oral daprodustat (Jesduvroq) for treating anemia in patients with chronic kidney disease...
